Sign in

CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

AN2 Therapeutics, Inc.

Sign in to watch
Ticker
ANTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
820606654
Phone
(650) 331-9090
Business address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Shareholder vote results
  4. 8-K Event Regulation FD disclosure · Other events
  5. 4 Insider Changes in Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. EFFECT Other Notice of Effectiveness
  13. 424B3 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. UPLOAD Other SEC-generated Letter
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. S-3 Offering Registration Statement

Page 2 of 20 · 387 filings